143 related articles for article (PubMed ID: 34536638)
1. Low skeletal muscle mass is a predictor of treatment related toxicity in oncologic patients. A meta-analysis.
Surov A; Pech M; Gessner D; Mikusko M; Fischer T; Alter M; Wienke A
Clin Nutr; 2021 Oct; 40(10):5298-5310. PubMed ID: 34536638
[TBL] [Abstract][Full Text] [Related]
2. Low skeletal muscle mass predicts treatment response in oncology: a meta-analysis.
Surov A; Strobel A; Borggrefe J; Wienke A
Eur Radiol; 2023 Sep; 33(9):6426-6437. PubMed ID: 36929392
[TBL] [Abstract][Full Text] [Related]
3. Low skeletal muscle mass in cholangiocarcinoma treated by surgical resection. A meta-analysis.
Surov A; Pech M; Omari J; Melekh B; March C; Perrakis A; Wienke A
HPB (Oxford); 2022 Jul; 24(7):997-1006. PubMed ID: 34906379
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis.
March C; Omari J; Thormann M; Pech M; Wienke A; Surov A
Clin Nutr ESPEN; 2022 Jun; 49():103-113. PubMed ID: 35623801
[TBL] [Abstract][Full Text] [Related]
5. The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis.
Huiskamp LFJ; Chargi N; Devriese LA; May AM; Huitema ADR; de Bree R
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33238530
[TBL] [Abstract][Full Text] [Related]
6. Low skeletal muscle mass predicts relevant clinical outcomes in head and neck squamous cell carcinoma. A meta analysis.
Surov A; Wienke A
Ther Adv Med Oncol; 2021; 13():17588359211008844. PubMed ID: 34035838
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of sarcopenia in patients with solid tumors: A meta-analysis based on 81,814 patients.
Surov A; Wienke A
JPEN J Parenter Enteral Nutr; 2022 Nov; 46(8):1761-1768. PubMed ID: 35633306
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Role of Low-Skeletal Muscle Mass on Staging Computed Tomography in Metastasized Colorectal Cancer: A Systematic Review and Meta-Analysis.
Meyer HJ; Strobel A; Wienke A; Surov A
Clin Colorectal Cancer; 2022 Sep; 21(3):e213-e225. PubMed ID: 35792019
[TBL] [Abstract][Full Text] [Related]
9. Low skeletal muscle mass and post-operative complications after surgery for liver malignancies: a meta-analysis.
Thormann M; Omari J; Pech M; Damm R; Croner R; Perrakis A; Strobel A; Wienke A; Surov A
Langenbecks Arch Surg; 2022 Jun; 407(4):1369-1379. PubMed ID: 35583832
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia as a Prognostic Marker for Survival in Gastric Cancer Patients Undergoing Palliative Chemotherapy. A Systematic Review and Meta Analysis.
Meyer HJ; Wienke A; Surov A
Nutr Cancer; 2022; 74(10):3518-3526. PubMed ID: 35603926
[TBL] [Abstract][Full Text] [Related]
11. CT-defined low-skeletal muscle mass as a prognostic marker for survival in prostate cancer: A systematic review and meta-analysis.
Meyer HJ; Wienke A; Surov A
Urol Oncol; 2022 Mar; 40(3):103.e9-103.e16. PubMed ID: 34483042
[TBL] [Abstract][Full Text] [Related]
12. Low skeletal muscle mass and treatment outcomes among adults with haematologic malignancies: A systematic review and meta-analysis.
Anabtawi NM; Pasala MS; Grimshaw AA; Kharel P; Bal S; Godby K; Siwakoti A; Buford TW; Bhatia S; Costa LJ; Williams GR; Giri S
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):1084-1093. PubMed ID: 38558541
[TBL] [Abstract][Full Text] [Related]
13. CT-defined sarcopenia predicts treatment response in primary central nervous system lymphomas.
Surov A; Meyer HJ; Hinnerichs M; Ferraro V; Zeremski V; Mougiakakos D; Saalfeld S; Wienke A; Strobel A; Wolleschak D
Eur Radiol; 2024 Feb; 34(2):790-796. PubMed ID: 37178198
[TBL] [Abstract][Full Text] [Related]
14. The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients.
Basile D; Parnofiello A; Vitale MG; Cortiula F; Gerratana L; Fanotto V; Lisanti C; Pelizzari G; Ongaro E; Bartoletti M; Garattini SK; Andreotti VJ; Bacco A; Iacono D; Bonotto M; Casagrande M; Ermacora P; Puglisi F; Pella N; Fasola G; Aprile G; Cardellino GG
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):368-377. PubMed ID: 30719874
[TBL] [Abstract][Full Text] [Related]
15. Low Skeletal Muscle Mass Predicts Relevant Outcomes in Palliative Urological Oncology: A Systematic Review and Meta-Analysis.
Meyer HJ; Wienke A; Zamsheva M; Surov A
Urol Int; 2023; 107(3):219-229. PubMed ID: 36455534
[TBL] [Abstract][Full Text] [Related]
16. Computed tomography-defined low skeletal muscle mass as a prognostic marker for short-term mortality in critically ill patients: A systematic review and meta-analysis.
Meyer HJ; Wienke A; Surov A
Nutrition; 2021; 91-92():111417. PubMed ID: 34399402
[TBL] [Abstract][Full Text] [Related]
17. CT assessment of preoperative nutritional status in gastric cancer: severe low skeletal muscle mass and obesity-related low skeletal muscle mass are unfavorable factors of postoperative complications.
Fang Z; Du F; Shang L; Liu J; Ren F; Liu Y; Wu H; Liu Y; Li P; Li L
Expert Rev Gastroenterol Hepatol; 2021 Mar; 15(3):317-324. PubMed ID: 33063547
[TBL] [Abstract][Full Text] [Related]
18. Low skeletal muscle mass as a risk factor for postoperative delirium in elderly patients undergoing colorectal cancer surgery.
Mosk CA; van Vugt JLA; de Jonge H; Witjes CD; Buettner S; Ijzermans JN; van der Laan L
Clin Interv Aging; 2018; 13():2097-2106. PubMed ID: 30425464
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Effect of Low Skeletal Muscle Mass among Hepatocellular Carcinoma Patients Undergoing Systemic Therapy: A Systematic Review and Meta-Analysis.
Kuo MH; Tseng CW; Hsu CS; Chen YC; Kao IT; Wu CY; Shao SC
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173893
[TBL] [Abstract][Full Text] [Related]
20. Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma.
Wu CH; Liang PC; Hsu CH; Chang FT; Shao YY; Ting-Fang Shih T
J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):559-566. PubMed ID: 32651043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
